Cargando…

Systemic administration of valproic acid and zonisamide promotes differentiation of induced pluripotent stem cell–derived dopaminergic neurons

Cell replacement therapy using embryonic stem cells (ESCs) and induced pluripotent stem cells (iPSCs) is a promising strategy for the treatment of neurologic diseases such as Parkinson's disease (PD). However, a limiting factor for effective cell transplantation is the low survival rate of graf...

Descripción completa

Detalles Bibliográficos
Autores principales:	Yoshikawa, Tatsuya, Samata, Bumpei, Ogura, Aya, Miyamoto, Susumu, Takahashi, Jun
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2013
Materias:	Neuroscience
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3573719/ https://www.ncbi.nlm.nih.gov/pubmed/23423767 http://dx.doi.org/10.3389/fncel.2013.00011

Ejemplares similares

Erratum: Systemic administration of valproic acid and zonisamide promotes differentiation of induced pluripotent stem cell-derived dopaminergic neurons
por: Yoshikawa, Tatsuya, et al.
Publicado: (2013)

Zonisamide promotes survival of human‐induced pluripotent stem cell‐derived dopaminergic neurons in the striatum of female rats
por: Miyawaki, Yoshifumi, et al.
Publicado: (2020)

Exercise Promotes Neurite Extensions from Grafted Dopaminergic Neurons in the Direction of the Dorsolateral Striatum in Parkinson’s Disease Model Rats
por: Torikoshi, Sadaharu, et al.
Publicado: (2020)

Isolation of Human Induced Pluripotent Stem Cell-Derived Dopaminergic Progenitors by Cell Sorting for Successful Transplantation
por: Doi, Daisuke, et al.
Publicado: (2014)

Estradiol Facilitates Functional Integration of iPSC-Derived Dopaminergic Neurons into Striatal Neuronal Circuits via Activation of Integrin α5β1
por: Nishimura, Kaneyasu, et al.
Publicado: (2016)

Origin of the Induced Pluripotent Stem Cells Affects Their Differentiation into Dopaminergic Neurons
por: Chlebanowska, Paula, et al.
Publicado: (2020)

Differentiation and Characterization of Dopaminergic Neurons From Baboon Induced Pluripotent Stem Cells
por: Grow, Douglas A., et al.
Publicado: (2016)

Cognitive Profile of Zonisamide and Valproic Acid in the Treatment of Idiopathic Generalized Epilepsy: A Comparative Observational Study
por: Ramirez-García, Teresa, et al.
Publicado: (2016)

Purification of functional human ES and iPSC-derived midbrain dopaminergic progenitors using LRTM1
por: Samata, Bumpei, et al.
Publicado: (2016)

Metabolic Profile Variations along the Differentiation of Human-Induced Pluripotent Stem Cells to Dopaminergic Neurons
por: Carsana, Emma Veronica, et al.
Publicado: (2022)

Three-dimensional induction of dorsal, intermediate and ventral spinal cord tissues from human pluripotent stem cells
por: Ogura, Takenori, et al.
Publicado: (2018)

Pluripotent Stem Cell-derived Dopaminergic Neurons for Studying Developmental Neurotoxicity
por: Kreutz, Anna, et al.
Publicado: (2023)

Modulation of Notch Signaling at Early Stages of Differentiation of Human Induced Pluripotent Stem Cells to Dopaminergic Neurons
por: Katolikova, Nataliia V., et al.
Publicado: (2023)

Pharmacokinetics of Single‐Dose Rectal Zonisamide Administration in Normal Dogs
por: Brewer, D.M., et al.
Publicado: (2015)

The Effect of Valproic Acid on Mesenchymal Pluripotent Cell Proliferation and Differentiation in Extracellular Matrices
por: Hatakeyama, Yuji, et al.
Publicado: (2011)

Expression Pattern of Trace Amine-Associated Receptors during Differentiation of Human Pluripotent Stem Cells to Dopaminergic Neurons
por: Katolikova, Nataliia V., et al.
Publicado: (2023)

Multiple factors to assist human-derived induced pluripotent stem cells to efficiently differentiate into midbrain dopaminergic neurons
por: Chen, Yalan, et al.
Publicado: (2023)

L1CAM Is a Marker for Enriching Corticospinal Motor Neurons in the Developing Brain
por: Samata, Bumpei, et al.
Publicado: (2020)

Comparative Study of Efficacy of Dopaminergic Neuron Differentiation between Embryonic Stem Cell and Protein-Based Induced Pluripotent Stem Cell
por: Kwon, Yoo-Wook, et al.
Publicado: (2014)

Valproic acid promotes the in vitro differentiation of human pluripotent stem cells into spermatogonial stem cell-like cells
por: Wang, Xiaotong, et al.
Publicado: (2021)

Zonisamide Administration Improves Fatty Acid β-Oxidation in Parkinson’s Disease
por: Ueno, Shin-Ichi, et al.
Publicado: (2018)

Hepatocellular necrosis with prominent regenerative reactions in a zonisamide administrated dog
por: TAKAMI, Yuki, et al.
Publicado: (2020)

Differentiation of rhesus adipose stem cells into dopaminergic neurons☆
por: Zhou, Yan, et al.
Publicado: (2012)

Zonisamide in the management of epilepsy in the elderly
por: Romigi, Andrea, et al.
Publicado: (2015)

A Comprehensive Analysis of Protocols for Deriving Dopaminergic Neurons from Human Pluripotent Stem Cells
por: Marton, Rebecca M., et al.
Publicado: (2018)

Protocol for measurement of calcium dysregulation in human induced pluripotent stem cell-derived dopaminergic neurons
por: Yin, Xiling, et al.
Publicado: (2021)

Pluripotent stem cell derived dopaminergic subpopulations model the selective neuron degeneration in Parkinson’s disease
por: Oosterveen, Tony, et al.
Publicado: (2021)

Optimized protocol for the generation of functional human induced-pluripotent-stem-cell-derived dopaminergic neurons
por: Sheta, Razan, et al.
Publicado: (2023)

Expansion of human midbrain floor plate progenitors from induced pluripotent stem cells increases dopaminergic neuron differentiation potential
por: Fedele, Stefania, et al.
Publicado: (2017)

Enhanced differentiation of human induced pluripotent stem cells toward the midbrain dopaminergic neuron lineage through GLYPICAN‐4 downregulation
por: Corti, Serena, et al.
Publicado: (2021)

Expression and role of nicotinic acetylcholine receptors during midbrain dopaminergic neuron differentiation from human induced pluripotent stem cells
por: Kato, Takeshi, et al.
Publicado: (2023)

Differentiation of adult human mesenchymal stem cells into dopaminergic neurons
por: Khademizadeh, Marjan, et al.
Publicado: (2019)

Cryopreservation of Induced Pluripotent Stem Cell-Derived Dopaminergic Neurospheres for Clinical Application
por: Hiramatsu, Satoe, et al.
Publicado: (2022)

Neuroprotective effects of zonisamide on cerebral ischemia injury via inhibition of neuronal apoptosis
por: He, Junna, et al.
Publicado: (2021)

Dopaminergic neurons differentiating from LRRK2 G2019S induced pluripotent stem cells show early neuritic branching defects
por: Borgs, Laurence, et al.
Publicado: (2016)

G2019S LRRK2 Mutation Enhances MPP(+)-Induced Inflammation of Human Induced Pluripotent Stem Cells-Differentiated Dopaminergic Neurons
por: Chen, Ying, et al.
Publicado: (2022)

Exploring pre-degenerative alterations in humans using induced pluripotent stem cell-derived dopaminergic neurons
por: Bono, Federica, et al.
Publicado: (2017)

Automated and manual patch clamp data of human induced pluripotent stem cell-derived dopaminergic neurons
por: Franz, Denise, et al.
Publicado: (2017)

High-throughput generation of midbrain dopaminergic neuron organoids from reporter human pluripotent stem cells
por: Sarrafha, Lily, et al.
Publicado: (2021)

Histone Deacetylase Inhibitor Valproic Acid Promotes the Differentiation of Human Induced Pluripotent Stem Cells into Hepatocyte-Like Cells
por: Kondo, Yuki, et al.
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_18g20urn1kol9vl57toq4les5r